Publications by authors named "Yossi Tal"

Claim this Profile
F
Freezing while preserving achievements: suspending quality indicators in healthcare, Israel's experience.
Yaron Niv, Dand Arad, Yossi Tal, Ilya Kagan

Int J Qual Health Care· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The public's perceptions of patient safety in healthcare.
Ilya Kagan, Dana Arad, Joseph Mendlovic, Yossi Tal, Yaron Niv

Isr J Health Policy Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The professional agenda and its effect on the implementation of telemedicine among primary care physicians: A qualitative study.
Avivit Golan Cohen, Yossi Tal, Daniel Hersh, Shlomo Vinker, Eugene Merzon, Atalia Tuval

J Telemed Telecare· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[THE IMPACT OF REGULATION AND CENTRAL MANAGEMENT ON PATIENT SAFETY IN ISRAEL].
Yaron Niv, Yossi Tal

Harefuah· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of behavioural changes in reporting adverse events early during COVID-19: An ambulatory care perspective in Israel.
Iris Reychav, Alon Yaakobi, Roger McHaney, Yossi Tal, Orly Manor

Int J Health Plann Manage· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crisis management for Patient Safety Officers: lessons learned from the Covid-19 pandemic.
Ilya Kagan, Dana Arad, Riki Aharoni, Yossi Tal, Yaron Niv

Isr J Health Policy Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CONFIDENTIALITY OF ADVERSE EVENTS INVESTIGATIONS - THE PRESENT STATUS AND WHAT IS NEEDED].
Yaron Niv, Ilia Kagan, Dana Arad, Riki Avrahami, Yossi Tal

Harefuah· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[SAFETY ROUNDS IN CLALIT SMILE CLINICS (CLALIT HEALTHCARE SERVICES) AS A MEANS FOR PROMOTING PATIENT SAFETY].
Ofer Cohen, Hagay Slutcki, Eva Sahar-Laor, Yossi Tal

Harefuah· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extension to 'combined SNA and LDA methods to understand adverse medical events': Doctor and nurse perspectives.
Lin Zhu, Iris Reychav, Roger McHaney, Arik Broda, Yossi Tal

Int J Risk Saf Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined SNA and LDA methods to understand adverse medical events.
Lin Zhu, Iris Reychav, Roger McHaney, Aric Broda, Yossi Tal

Int J Risk Saf Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.
Katrin Lorenz, Yvonne Scheller, Katharina Bell, Franz Grus, Katharina A Ponto, Yossi Tal

Trials· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[IS IT POSSIBLE TO REDUCE THE INCIDENCE OF CONGENITAL ANOMALIES? ANALYSIS OF ADVERSE OBSTETRICS CLINICAL EVENTS].
Eduardo Schejter, Dorith Ben-Hur, Arik Broda, Orly Manor, Iris Levy, Yossi Tal

Harefuah· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous drug release by sea anemone Nematostella vectensis stinging microcapsules.
Yossi Tal, Ari Ayalon, Agnesa Sharaev, Zoya Kazir, Vera Brekhman

Mar Drugs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of soluble protein contents from the nematocysts of a model sea anemone sheds light on venom evolution.
Yehu Moran, Daniela Praher, Ami Schlesinger, Ari Ayalon, Yossi Tal

Mar Biotechnol (NY)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a tool to preserve eye contact with patients undergoing colonoscopy for pain monitoring.
Yaron Niv, Yossi Tal

Drug Healthc Patient Saf· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal delivery of scopolamine by natural submicron injectors: in-vivo study in pig.
Esther Shaoul, Ari Ayalon, Yossi Tal, Tamar Lotan

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of 7-year physician-reported adverse events in esophagogastroduodenoscopy.
Yaron Niv, Yael Gershtansky, Yossi Tal, Ron S Kenett, Shlomo Birkenfeld

J Patient Saf· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate topical drug delivery by natural submicron injectors.
Ari Ayalon, Iris Shichor, Yossi Tal, Tamar Lotan

Int J Pharm· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS): analysis of 7-year physician-reported adverse events.
Yaron Niv, Yael Gershtansky, Ron S Kenett, Yossi Tal, Shlomo Birkenfeld

Drug Healthc Patient Saf· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications in colonoscopy: analysis of 7-year physician-reported adverse events.
Yaron Niv, Yael Gershtansky, Ron S Kenett, Yossi Tal, Shlomo Birkenfeld

Eur J Gastroenterol Hepatol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of aerobic and anaerobic ammonia-oxidizing bacteria in marine sponges.
Naglaa M Mohamed, Keiko Saito, Yossi Tal, Russell T Hill

ISME J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity and expression of nitrogen fixation genes in bacterial symbionts of marine sponges.
Naglaa M Mohamed, Albert S Colman, Yossi Tal, Russell T Hill

Environ Microbiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-trimester maternal serum PP13 in the risk assessment for preeclampsia.
Roberto Romero, Juan Pedro Kusanovic, Nandor Gabor Than, Offer Erez, Francesca Gotsch, Hamutal Meiri, Yossi Tal

Am J Obstet Gynecol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Ilana Chafetz, Ido Kuhnreich, Marei Sammar, Yossi Tal, Yair Gibor, Hamutal Meiri

Am J Obstet Gynecol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaerobic ammonium-oxidizing (anammox) bacteria and associated activity in fixed-film biofilters of a marine recirculating aquaculture system.
Yossi Tal, Joy E M Watts, Harold J Schreier

Appl Environ Microbiol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis